Keyphrases
Venous Thromboembolism
100%
Management Guidelines
100%
Antiphospholipid Syndrome
100%
Secondary Prophylaxis
100%
International Normalized Ratio
40%
Recurrent Venous Thromboembolism
40%
Bleeding
20%
Warfarin
20%
Anticoagulation
20%
Thrombosis
20%
Anticardiolipin Antibodies
20%
Published Data
20%
Decision Analysis
20%
Recurrence Risk
20%
Lupus Anticoagulant
20%
Individual Risk Factors
20%
General Practice
20%
Antiphospholipid
20%
Oral Anticoagulant Therapy
20%
Thrombophilic
20%
Individualized Treatment
20%
Vessel Tree
20%
Nursing and Health Professions
Practice Guideline
100%
Venous Thromboembolism
100%
Antiphospholipid Syndrome
100%
International Normalized Ratio
50%
Recurrent Disease
50%
Warfarin
16%
Anticoagulant Agent
16%
Anticoagulant Therapy
16%
Anticoagulation
16%
General Practice
16%
Lupus Anticoagulant
16%
Thrombosis
16%
Cardiolipin Antibody
16%
Medicine and Dentistry
Venous Thromboembolism
100%
Antiphospholipid Syndrome
100%
Recurrent Disease
50%
Prospective Study
16%
Anticoagulant Therapy
16%
Warfarin
16%
Antithrombotic
16%
Anticoagulation
16%
Thrombosis
16%
Cardiolipin Antibody
16%
Lupus Anticoagulant
16%
General Medicine
16%
Anti-Cardiolipin Antibodies
16%
Agricultural and Biological Sciences
Risk Factor
100%
Prospective Study
100%
Warfarin
100%
Anti-Cardiolipin Antibodies
100%
Pharmacology, Toxicology and Pharmaceutical Science
Venous Thromboembolism
100%
Antiphospholipid Syndrome
100%
Recurrent Disease
50%
Tree
16%
Prospective Study
16%
Anticoagulant Agent
16%
Warfarin
16%
Thrombosis
16%
Lupus Anticoagulant
16%
Cardiolipin Antibody
16%
Neuroscience
Antiphospholipid Syndrome
100%
Antithrombotic
20%
Warfarin
20%
Cardiolipin Antibody
20%
Lupus Anticoagulant
20%